These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 5452841

  • 1. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J, Lyczewska J, Styszewska H, Walczak J.
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract] [Full Text] [Related]

  • 2. [Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests].
    Pruszyńska S.
    Gruzlica; 1971 Dec; 39(12):1211-8. PubMed ID: 5139240
    [No Abstract] [Full Text] [Related]

  • 3. [Characteristics of drug-induced hepatitis in patients with tuberculosis].
    Vil'derman AM.
    Probl Tuberk; 1972 Dec; 50(5):59-63. PubMed ID: 4112966
    [No Abstract] [Full Text] [Related]

  • 4. [On the problem of chronic liver damage following drug therapy of tuberculosis].
    Petera V, Klapálek D, Paichl P, Pecený A.
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):250-2. PubMed ID: 5888913
    [No Abstract] [Full Text] [Related]

  • 5. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK.
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO, Karachunskiĭ MA, Kolosovskaia VP.
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract] [Full Text] [Related]

  • 7. [Toxicity of antitubercular agents for the liver].
    Dölle W.
    Dtsch Med Wochenschr; 1973 Jan 12; 98(2):74. PubMed ID: 4683834
    [No Abstract] [Full Text] [Related]

  • 8. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV.
    Probl Tuberk; 1968 Jan 12; 46(8):43-7. PubMed ID: 5709113
    [No Abstract] [Full Text] [Related]

  • 9. [Medication-induced hepatic lesions in patients with pulmonary tuberculosis].
    Gned'ko NI.
    Voen Med Zh; 2002 May 12; 323(5):56-8. PubMed ID: 12073843
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of pyrazinamide on the liver of tuberculosis patients. Electron microscopic study].
    Pilheu JA, de Salvo MC, Koch OR, Arias RF.
    Bull Int Union Tuberc; 1984 Sep 12; 59(3):145-7. PubMed ID: 6518323
    [No Abstract] [Full Text] [Related]

  • 11. Side effects of drugs used to treat tuberculosis.
    Newton RW.
    Scott Med J; 1975 Mar 12; 20(2):47-9. PubMed ID: 47648
    [No Abstract] [Full Text] [Related]

  • 12. Hepatic complications of antituberculous therapy.
    Rossouw JE, Saunders SJ.
    Q J Med; 1975 Jan 12; 44(173):1-16. PubMed ID: 50605
    [Abstract] [Full Text] [Related]

  • 13. [Effects of pyrazinamide on the liver in patients with tuberculosis. An ultrastructural study].
    Pilheu JA, de Salvo MC, Arias RF, Koch OR.
    Medicina (B Aires); 1985 Jan 12; 45(1):15-9. PubMed ID: 3880102
    [No Abstract] [Full Text] [Related]

  • 14. Side effects and toxicity of ethionamide and prothionamide.
    Tala E, Tevola K.
    Ann Clin Res; 1969 May 12; 1(1):32-5. PubMed ID: 5350768
    [No Abstract] [Full Text] [Related]

  • 15. [Centrilobular liver necrosis following antimycobacterial treatment].
    Beckert W.
    Z Erkr Atmungsorgane Folia Bronchol; 1971 Aug 12; 135(1):11-7. PubMed ID: 5209484
    [No Abstract] [Full Text] [Related]

  • 16. [Centrilobular parenchymal necrosis of the liver. A contribution to the knowledge of drug induced lesions of the liver (author's transl)].
    Beckert W.
    Zentralbl Allg Pathol; 1973 Aug 12; 117(3):219-26. PubMed ID: 4520112
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical studies on the ketogenic effect of certain antitubercular drugs in patients with diabetes and pulmonary tuberculosis].
    Onisk J.
    Wiad Lek; 1968 May 01; 21(9):743-5. PubMed ID: 4875998
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR, Lind A, Rist N.
    Bull Int Union Tuberc; 1969 Aug 01; 42():7-57. PubMed ID: 5004884
    [No Abstract] [Full Text] [Related]

  • 19. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M, Endo K, Noguchi T, Nakano M.
    Iryo; 1966 Apr 01; 20(4):347-53. PubMed ID: 5974193
    [No Abstract] [Full Text] [Related]

  • 20. [Liver injury under tuberculostatic treatment].
    Fattinger K, Braunschweig S, Reichen J, Meier-Abt PJ, Krähenbühl S.
    Praxis (Bern 1994); 1997 Apr 09; 86(15):626-9. PubMed ID: 9213916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.